Scilex Holding Company Closes $15 Million Offering, Company Shares Drop 52%
Scilex Holding Company recently announced the successful closing of a $15 million registered direct offering of common stock and warrants.The offering consisted of 15,000,000 shares of common stock at a purchase price of $1.00 per share, along with warrants to purchase up to an additional 15,000,000 shares of common stock.The warrants have an exercise price of $1.10 per share, becoming exercisable six months after issuance and expiring five years after issuance.
Despite this positive news, Scilex Holding Company’s share price currently stands at $0.85, reflecting a year-to-date performance decrease of -52.12%. This significant drop in share price may be attributed to various factors, including market conditions, investor sentiment, and overall performance of the company.
Investors and analysts will be closely monitoring Scilex Holding Company’s next steps following the offering, as the company continues to focus on acquiring, developing, and commercializing non-opioid pain management products.With the uncertainty surrounding the company’s share performance, it remains to be seen how Scilex Holding Company will navigate through these challenges and potentially regain investor confidence.
Comments